European guidelines for sclerotherapy in chronic venous disorders.

Détails

ID Serval
serval:BIB_57EA2E11EBC0
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
European guidelines for sclerotherapy in chronic venous disorders.
Périodique
Phlebology / Venous Forum of the Royal Society of Medicine
Auteur(s)
Rabe E., Breu F., Cavezzi A., Smith P.C., Frullini A., Gillet J., Guex J., Hamel-Desnos C., Kern P., Partsch B., Ramelet A., Tessari L., Pannier F.
Collaborateur(s)
for the Guideline Group
ISSN
1758-1125 (Electronic)
ISSN-L
0268-3555
Statut éditorial
Publié
Date de publication
2013
Peer-reviewed
Oui
Volume
29
Numéro
6
Pages
338-354
Langue
anglais
Notes
Publication types: JOURNAL ARTICLE
Résumé
AIM: Sclerotherapy is the targeted chemical ablation of varicose veins by intravenous injection of a liquid or foamed sclerosing drug. The treated veins may be intradermal, subcutaneous, and/or transfascial as well as superficial and deep in venous malformations. The aim of this guideline is to give evidence-based recommendations for liquid and foam sclerotherapy.
METHODS: This guideline was drafted on behalf of 23 European Phlebological Societies during a Guideline Conference on 7-10 May 2012 in Mainz. The conference was organized by the German Society of Phlebology. These guidelines review the present state of knowledge as reflected in published medical literature. The regulatory situation of sclerosant drugs differs from country to country but this has not been considered in this document. The recommendations of this guideline are graded according to the American College of Chest Physicians Task Force recommendations on Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines.
RESULTS: This guideline focuses on the two sclerosing drugs which are licensed in the majority of the European countries, polidocanol and sodium tetradecyl sulphate. Other sclerosants are not discussed in detail. The guideline gives recommendations concerning indications, contraindications, side-effects, concentrations, volumes, technique and efficacy of liquid and foam sclerotherapy of varicose veins and venous malformations.
Pubmed
Web of science
Création de la notice
14/06/2014 15:15
Dernière modification de la notice
20/08/2019 15:11
Données d'usage